Detalhe da pesquisa
1.
Phase I study combining treatment with temsirolimus and sunitinib malate in patients with advanced renal cell carcinoma.
Clin Genitourin Cancer
; 7(1): 24-7, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19213664
2.
Gemcitabine/carboplatin in patients with metastatic non-small-cell lung cancer: phase II study of 28-day and 21-day schedules.
Clin Lung Cancer
; 7(3): 202-7, 2005 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-16354316
3.
Interleukin-12 (IL-12) ameliorates the effects of porcine respiratory and reproductive syndrome virus (PRRSV) infection.
Vet Immunol Immunopathol
; 107(1-2): 105-18, 2005 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15936827
4.
Inverse probability weighting to control for censoring in a post hoc analysis of quality-adjusted survival data from a clinical trial of temsirolimus for renal cell carcinoma.
J Med Econ
; 14(2): 245-52, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21417551
5.
The antineoplastic agent bryostatin-1 differentially regulates IFN-gamma receptor subunits in monocytic cells: transcriptional and posttranscriptional control of IFN-gamma R2.
J Immunol
; 177(4): 2707-16, 2006 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16888033
6.
Phase II study of pemetrexed for second-line treatment of transitional cell cancer of the urothelium.
J Clin Oncol
; 24(21): 3451-7, 2006 Jul 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-16849761
7.
A randomized phase II trial using two different treatment schedules of gemcitabine and carboplatin in patients with advanced non-small-cell lung cancer.
J Thorac Oncol
; 1(1): 19-24, 2006 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17409822
8.
Phase II study of pemetrexed in combination with carboplatin in the first-line treatment of advanced nonsmall cell lung cancer.
Cancer
; 104(11): 2449-56, 2005 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16258975
9.
IL-4 synergistically enhances both IL-2- and IL-12-induced IFN-gamma expression in murine NK cells.
Blood
; 102(1): 207-14, 2003 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12637316